70 related articles for article (PubMed ID: 8113970)
21. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
Baumhaker Y; Gafni M; Keren O; Sarne Y
Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
[TBL] [Abstract][Full Text] [Related]
22. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
Murthy KS; Makhlouf GM
Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
[TBL] [Abstract][Full Text] [Related]
23. kappa-Opioid inhibition of [3H]dopamine release from rat ventral mesencephalic dissociated cell cultures.
Smith JA; Loughlin SE; Leslie FM
Mol Pharmacol; 1992 Oct; 42(4):575-83. PubMed ID: 1359395
[TBL] [Abstract][Full Text] [Related]
24. Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro.
McFadzean I; Lacey MG; Hill RG; Henderson G
Neuroscience; 1987 Jan; 20(1):231-9. PubMed ID: 3031541
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of μ-opioid receptor desensitization by nitric oxide in rat locus coeruleus neurons: involvement of reactive oxygen species.
Llorente J; Santamarta MT; Henderson G; Pineda J
J Pharmacol Exp Ther; 2012 Aug; 342(2):552-60. PubMed ID: 22593094
[TBL] [Abstract][Full Text] [Related]
26. kappa-Opioid receptor agonist-induced prolactin release in primates is blocked by dopamine D(2)-like receptor agonists.
Butelman ER; Kreek MJ
Eur J Pharmacol; 2001 Jul; 423(2-3):243-9. PubMed ID: 11448491
[TBL] [Abstract][Full Text] [Related]
27. kappa-Opioid tolerance and dependence in cultures of dopaminergic midbrain neurons.
Dalman FC; O'Malley KL
J Neurosci; 1999 Jul; 19(14):5750-7. PubMed ID: 10407016
[TBL] [Abstract][Full Text] [Related]
28. mu-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure.
Van Vliet BJ; De Vries TJ; Wardeh G; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1991 Oct; 208(2):105-11. PubMed ID: 1666051
[TBL] [Abstract][Full Text] [Related]
29. Effect of chronic prenatal morphine treatment of mu-opioid receptor-regulated adenylate cyclase activity and neurotransmitter release in rat brain slices.
De Vries TJ; Van Vliet BJ; Hogenboom F; Wardeh G; Van der Laan JW; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1991 Oct; 208(2):97-104. PubMed ID: 1686867
[TBL] [Abstract][Full Text] [Related]
30. Stimulus-evoked release of tritiated monoamines from rat periaqueductal gray slices in vitro and its receptor-mediated modulation.
Versteeg DH; Csikós T; Spierenburg H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):595-602. PubMed ID: 1658661
[TBL] [Abstract][Full Text] [Related]
31. Involvement of neuronal nitric oxide synthase in desensitisation of µ-opioid receptors in the rat locus coeruleus.
Santamarta MT; Llorente J; Mendiguren A; Pineda J
J Psychopharmacol; 2014 Oct; 28(10):903-14. PubMed ID: 24961237
[TBL] [Abstract][Full Text] [Related]
32. [Catecholamines in the brain structures of rats responding differently to the "open field" test].
Belova TI; Kvetnanskiĭ R; Dobrakovova M; Oprshalova Z; Ivanova TM
Biull Eksp Biol Med; 1981 Feb; 91(2):136-8. PubMed ID: 7225543
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of μ-opioid receptor desensitization by orexin-A in rat locus coeruleus neurons.
Mohammad Ahmadi Soleimani S; Azizi H; Pachenari N; Mirnajafi-Zadeh J; Semnanian S
Neuropeptides; 2017 Jun; 63():28-36. PubMed ID: 28385341
[TBL] [Abstract][Full Text] [Related]
34. Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system.
Kreibich A; Reyes BA; Curtis AL; Ecke L; Chavkin C; Van Bockstaele EJ; Valentino RJ
J Neurosci; 2008 Jun; 28(25):6516-25. PubMed ID: 18562623
[TBL] [Abstract][Full Text] [Related]
35. Evidence for multiple mechanisms of kappa opioid tolerance in mesencephalic cultures.
Sun XG; Dalman FC
Brain Res; 2003 May; 973(1):122-30. PubMed ID: 12729961
[TBL] [Abstract][Full Text] [Related]
36. Opioid desensitization: interactions with G-protein-coupled receptors in the locus coeruleus.
Fiorillo CD; Williams JT
J Neurosci; 1996 Feb; 16(4):1479-85. PubMed ID: 8778299
[TBL] [Abstract][Full Text] [Related]
37. Presynaptic inhibition of GABA(B)-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal.
Shoji Y; Delfs J; Williams JT
J Neurosci; 1999 Mar; 19(6):2347-55. PubMed ID: 10066284
[TBL] [Abstract][Full Text] [Related]
38. Transient homologous mu-opioid receptor desensitization in rat locus coeruleus neurons.
Harris GC; Williams JT
J Neurosci; 1991 Aug; 11(8):2574-81. PubMed ID: 1651377
[TBL] [Abstract][Full Text] [Related]
39. Effects of chronic activation of dopamine D-2 receptors in cultures of rat fetal dopaminergic neurons: indications for alterations in functional activity.
Van Muiswinkel FL; Jongenelen CA; Schepens HT; Stoof JC; Drukarch B
Brain Res Dev Brain Res; 1995 Mar; 85(1):128-36. PubMed ID: 7781159
[TBL] [Abstract][Full Text] [Related]
40. Modulation of dopamine binding in the fetal rat: effects of milk and exogenous opioid manipulation.
Andersen SL; Umphress SM; Robinson SR; Smotherman WP; Ward KM; Kehoe P
Pharmacol Biochem Behav; 1993 Oct; 46(2):377-81. PubMed ID: 8265693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
